Evidence map›Paper›PMID 33531015›Full record

ArticleBMC medicine2021

The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.

C N Mburu, J Ojal, R Chebet, D Akech, B Karia, J Tuju, A Sigilai, K Abbas, M Jit, S Funk and 9 more

Abstract read
In one paragraph

Article in BMC medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

C N MburuKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. CMburu@kemri-wellcome.org.
J OjalKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
R ChebetKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
D AkechKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
B KariaKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
J TujuKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
A SigilaiKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
K AbbasDepartment of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
M JitDepartment of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
S FunkDepartment of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
G SmitsDepartment of Immunosurveillance, Centre for Infectious Diseases Control, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
P G M van GageldonkDepartment of Immunosurveillance, Centre for Infectious Diseases Control, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
F R M van der KlisDepartment of Immunosurveillance, Centre for Infectious Diseases Control, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
C TabuNational Vaccine and Immunisation Programme, Ministry of Health, Nairobi, Kenya.
D J NokesKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
LSHTM CMMID COVID-19 Working Group
Jag ScottKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
S Flasche *Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Imo Adetifa *KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. IAdetifa@kemri-wellcome.org.

Funding

Gates Foundation INV-001754Gates Foundation INV-003174Medical Research Council MC_PC_19065Medical Research Council MR/S003975/1Medical Research Council MR/S005293/1Wellcome Trust
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has disrupted routine measles immunisation and supplementary immunisation activities (SIAs) in most countries including Kenya. We assessed the risk of measles outbreaks during the pandemic in Kenya as a case study for the African Region.

methodsCombining measles serological data, local contact patterns, and vaccination coverage into a cohort model, we predicted the age-adjusted population immunity in Kenya and estimated the probability of outbreaks when contact-reducing COVID-19 interventions are lifted. We considered various scenarios for reduced measles vaccination coverage from April 2020.

resultsIn February 2020, when a scheduled SIA was postponed, population immunity was close to the herd immunity threshold and the probability of a large outbreak was 34% (8-54). As the COVID-19 contact restrictions are nearly fully eased, from December 2020, the probability of a large measles outbreak will increase to 38% (19-54), 46% (30-59), and 54% (43-64) assuming a 15%, 50%, and 100% reduction in measles vaccination coverage. By December 2021, this risk increases further to 43% (25-56), 54% (43-63), and 67% (59-72) for the same coverage scenarios respectively. However, the increased risk of a measles outbreak following the lifting of all restrictions can be overcome by conducting a SIA with ≥ 95% coverage in under-fives.

conclusionWhile contact restrictions sufficient for SAR-CoV-2 control temporarily reduce measles transmissibility and the risk of an outbreak from a measles immunity gap, this risk rises rapidly once these restrictions are lifted. Implementing delayed SIAs will be critical for prevention of measles outbreaks given the roll-back of contact restrictions in Kenya.

Indexed as

SARS-CoV-2AdolescentChildChild, PreschoolCOVID-19Disease OutbreaksFemaleHumansImmunization ProgramsInfantInfant, NewbornKenyaMaleMeaslesMeasles VaccineVaccination CoverageMeasles VaccineCOVID-19MeaslesOutbreakSupplementary immunisation activitiesVaccination coverage

Identifiers

PMID33531015
PMCPMC7854026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.